The researchers from the Moscow Institute of Physics and Technology (MIPT) have compared gene expression in young and elderly patients' cells.
Each cell uses particular schemes of molecular interaction, which physiologists call inter-cellular signalling pathways.
A signalling pathway is a chain of sequential events of interaction between certain molecules which make the cell respond to stimulation.
The team of experts from MIPT and other Russian and British organisations suggested comparing peculiarities of signalling pathways activation in young and ageing cells.
This information is then expanded with the available data on the impact of various substances on signalling pathways.
Scientists point out that their algorithm can be used in rapid and inexpensive search for drugs which can minimise the difference between the cells of young and elderly patients.
This means that it will be possible to speed up the search for longevity drugs and decrease its cost, researchers said.
What is more, this will be achieved not by simply fighting some particular diseases, but by a complex influence on the mechanisms of ageing, they said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
